MeiraGTx Holdings (MGTX) Gains from Investment Securities (2017 - 2025)
MeiraGTx Holdings (MGTX) reported Gains from Investment Securities of -$200000.0 for Q4 2025, down 119.34% on a YoY basis from $1.0 million in Q4 2024, and down 102.51% quarter-over-quarter from $8.0 million in Q3 2025.
MeiraGTx Holdings (MGTX) Gains from Investment Securities (2017 - 2025) Analysis & Trends
MeiraGTx Holdings has reported Gains from Investment Securities for 9 years, with the latest figure at -$200000.0 in Q4 2025.
- For the quarter ending Q4 2025, Gains from Investment Securities fell 119.34% year-over-year to -$200000.0; the trailing twelve-month figure through Dec 2025 stood at $5.4 million (down 1.86% YoY), and the FY2025 full-year result was $557015.0, down 93.23% from the prior year.
- Gains from Investment Securities for Q4 2025 stood at -$200000.0, down from $8.0 million in the prior quarter.
- The five-year high for Gains from Investment Securities was $8.2 million in Q1 2023, with the low at -$200000.0 in Q4 2025.
- Historically, Gains from Investment Securities has averaged $2.2 million across 5 years, with a median of $1.0 million in 2024.
- The largest YoY upside for Gains from Investment Securities was 27845.14% in 2025 against a maximum downside of 119.34% in 2025.
- MeiraGTx Holdings' Gains from Investment Securities stood at $1.6 million in 2021, then surged by 63.5% to $2.7 million in 2022, then slumped by 32.63% to $1.8 million in 2023, then tumbled by 42.36% to $1.0 million in 2024, then tumbled by 119.34% to -$200000.0 in 2025.
- The last three Gains from Investment Securities figures came in at -$200000.0 (Q4 2025), $8.0 million (Q3 2025), and $387769.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | MeiraGTx Holdings | 910.47 Mn | 844.54 Mn | 74.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -200,000.00 |
| Dec 31, 2025 | -200,000.00 |
| Sep 30, 2025 | 7.96 Mn |
| Sep 30, 2025 | 7.96 Mn |
| Jun 30, 2025 | 387,769.00 |
| Jun 30, 2025 | 387,769.00 |
| Mar 31, 2025 | 2.76 Mn |
| Mar 31, 2025 | 2.76 Mn |
| Dec 31, 2024 | 1.03 Mn |
| Dec 31, 2024 | 1.03 Mn |
| Sep 30, 2024 | 28,500.00 |
| Sep 30, 2024 | 28,500.00 |
| Jun 30, 2024 | 348,652.00 |
| Jun 30, 2024 | 348,652.00 |
| Mar 31, 2024 | 348,652.00 |
| Mar 31, 2024 | 348,652.00 |
| Dec 31, 2023 | 1.79 Mn |
| Dec 31, 2023 | 1.79 Mn |
| Sep 30, 2023 | 142,577.00 |
| Sep 30, 2023 | 142,577.00 |